baseline 105 dGA |
5 days after the 1st treatment 111 dGA |
14 days after the 2nd treatment 127 dGA |
||||
---|---|---|---|---|---|---|
vehicle | betamethasone | vehicle | betamethasone | vehicle | betamethasone | |
Fetal | ||||||
FBP (mmHg) | 38 ± 1.2 | 37 ± 1.3 | 40 ± 1.0 | 37 ± 0.8 | 44 ± 1.4 * | 43 ± 1.8 * |
pH | 7.36 ± 0.01 | 7.37 ± 0.01 | 7.35 ± 0.01 | 7.36 ± 0.03 | 7.36 ± 0.01 | 7.37 ± 0.01 |
pCO2 (mmHg) | 46.3 ± 1.4 | 48.4 ± 0.9 | 49.0 ± 1.6 | 47.8 ± 1.7 | 48.8 ± 1.5 | 47.9 ± 1.3 |
pO2 (mmHg) | 27.8 ± 1.0 | 26.6 ± 1.1 | 24.7 ± 1.3 | 24.9 ± 0.6 | 24.0 ± 1.2 | 27.7 ± 1.8 |
Hb (mg dl−1) | 8.0 ± 0.3 | 8.8 ± 0.2 | 8.0 ± 0.3 | 7.7 ± 0.3 | 9.6 ± 0.4 | 8.7 ± 0.2 |
O2 sat (%) | 75.6 ± 1.3 | 78.0 ± 2.8 | 76.4 ± 6.6 | 80.5 ± 1.9 | 74.5 ± 2.4 | 80.5 ± 2.3 |
Maternal | ||||||
pH | 7.46 ± 0.02 | 7.48 ± 0.01 | 7.44 ± 0.01 | 7.45 ± 0.01 | 7.46 ± 0.02 # | 7.50 ± 0.01 |
pCO2 (mmHg) | 32.0 ± 1.9 | 34.1 ± 0.9 | 31.6 ± 3.4 | 33.2 ± 1.4 | 31.5 ± 2.1 | 34.6 ± 1.0 |
pO2 (mmHg) | 123.0 ± 6.0 | 111.1 ± 5.5 | 117.5 ± 7.2 | 111.8 ± 2.7 | 119.0 ± 4.5 | 112.9 ± 2.3 |
Hb (mg dl−1) | 8.5 ± 0.7 | 9.7 ± 0.5 | 8.9 ± 0.4 | 8.7 ± 0.2 | 9.4 ± 0.4 | 9.0 ± 0.3 |
O2 sat (%) | 96.2 ± 0.6 | 97.9 ± 0.6 | 97.9 ± 0.7 | 97.9 ± 0.4 | 98.3 ± 0.7 | 98.3 ± 0.3 |